Climedo’s Post

We are looking forward to the upcoming Patients as Partners in Clinical Research EU conference. Don't miss our presentation on May 15, Implementing a Patient Insights Framework to Enhance Clinical Development and Patient Engagement. Join Sarah Lucas-Eaton, Patient Strategy Director, Lumanity, Samantha Knott, Global Patient Partnership Leader at Roche, and Nichola Gokool, Senior Director, Patient Partnerships at Parexel, as they address the action steps the industry can take to advance patient engagement initiatives and how this transformation will allow for faster and more efficient clinical development. The panel will focus on: - Strategies to incorporate patient insights to adapt the trial design and make participation more accessible - Identifying patient requirements at different stages and how to turn those insights into action - Making patient input actionable for medicines development - How to keep patients engaged throughout the clinical trial and how to leverage those patient insights to improve the process And be sure to stop by our exhibit booth to connect with our staff on-site in London! Learn more at https://buff.ly/442eZz3 #patientengagement #patientempowerment #patientadvocacy #patientsaspartners #PatientsEU2024 #clinicalresearch #patientvoice #patientpartnerships

We are looking forward to the upcoming Patients as Partners in Clinical Research EU conference. Don't miss our presentation on May 15, Implementing a Patient Insights Framework to Enhance Clinical Development and Patient Engagement. Join Sarah Lucas-Eaton, Patient Strategy Director, Lumanity, Samantha Knott, Global Patient Partnership Leader at Roche, and Nichola Gokool, Senior Director, Patient Partnerships at Parexel, as they address the action steps the industry can take to advance patient engagement initiatives and how this transformation will allow for faster and more efficient clinical development. The panel will focus on: - Strategies to incorporate patient insights to adapt the trial design and make participation more accessible - Identifying patient requirements at different stages and how to turn those insights into action - Making patient input actionable for medicines development - How to keep patients engaged throughout the clinical trial and how to leverage those patient insights to improve the process And be sure to stop by our exhibit booth to connect with our staff on-site in London! Learn more at https://buff.ly/3xyKYuB #patientengagement #patientempowerment #patientadvocacy #patientsaspartners #PatientsEU2024 #clinicalresearch #patientvoice #patientpartnerships

We are looking forward to the upcoming Patients as Partners in Clinical Research EU conference. Don't miss our presentation on May 15, Implementing a Patient Insights Framework to Enhance Clinical Development and Patient Engagement. Join Sarah Lucas-Eaton, Patient Strategy Director, Lumanity, Samantha Knott, Global Patient Partnership Leader at Roche, and Nichola Gokool, Senior Director, Patient Partnerships at Parexel, as they address the action steps the industry can take to advance patient engagement initiatives and how this transformation will allow for faster and more efficient clinical development. The panel will focus on: - Strategies to incorporate patient insights to adapt the trial design and make participation more accessible - Identifying patient requirements at different stages and how to turn those insights into action - Making patient input actionable for medicines development - How to keep patients engaged throughout the clinical trial and how to leverage those patient insights to improve the process And be sure to stop by our exhibit booth to connect with our staff on-site in London! Learn more at https://buff.ly/3JkQ8wX #patientengagement #patientempowerment #patientadvocacy #patientsaspartners #PatientsEU2024 #clinicalresearch #patientvoice #patientpartnerships

At SCOPE's annual 2024 meeting, industry leaders discussed ideas about improving clinical trials using DHTs and digital measurement. Here are 10 takeaways: https://hubs.la/Q02p-D170 #clinicaltrials #sdigitalbiomarkers #clinicaltrials

At SCOPE's annual 2024 meeting, industry leaders discussed ideas about improving clinical trials using DHTs and digital measurement. Here are 10 takeaways: https://hubs.la/Q02p-fZl0 #clinicaltrials #sdigitalbiomarkers #clinicaltrials

Why Sponsors Should Partner with Physician-Owned Clinical Research Sites 🤝🔬 Physician-owned sites offer unique benefits that can significantly enhance the success of clinical trials. Here's why partnering with them is a smart move: 🔹 Increased Patient Trust: Patients inherently trust us as their physicians, resulting in higher and quality enrollment rates and improved trial retention. 🔹 Better Compliance: Trust in physicians fosters adherence to study protocols, leading to accurate, high-quality data crucial for any trial success. 🔹 Enhanced Data Quality: Our passion for patient health enables early issue detection and personalized care, ultimately enhancing trial outcomes. 🔹 Stronger Patient-Physician Relationships: The existing connection boosts participant engagement, reduces dropout rates, and ensures reliable long-term data. 🔹 Streamlined Operations: Physician oversight ensures efficient communication and fewer protocol deviations, contributing to smooth trial operations. Partnering with physician-owned clinical research sites like HMG Clinical Research can truly elevate the quality and success of your clinical trials. #ClinicalResearch #Healthcare #PhysicianOwnedSites #ClinicalTrials #Chronicpainmanagement #CompassionateCare #Qualitydata

Simplifying Informed Consent Forms (ICFs) could be the game-changer your clinical trials need... Recently we sat down with Philippa Pristerà, our Strategy Director (Patient Insights and Engagement) who shared some insights on the critical role of streamlined ICFs in enhancing patient involvement in clinical trials.  Lengthy and overly complex ICFs can deter potential participants, creating barriers to trial enrolment. But by making ICFs more accessible and user-friendly, we open the door to broader patient recruitment and participation, paving the way for more inclusive and patient-centric trials. 🤝 📩 For a deeper dive into supporting a patient-first approach in clinical trials, download our latest report, "Integrating Patient First into Medicine Development": https://lnkd.in/eM3qH7hc

Clinical Development Strategy An effective clinical trial strategy boosts your clinical trial success rate! 📊🔬 It elevates trial outcomes through optimized trial design, enhanced patient recruitment, and advanced data analysis. Click the link below to learn about clinical development strategies. #ClinicalTrials #TrialStrategy #ResearchExcellence 👉 Contact @Credevo for clinical development strategies for your clinical trials https://buff.ly/45cM3ot

Interesting concept that can potentially help patients while integrating best practice to improve healthcare delivery and outcomes.

Figures from a new MTPConnect report reveal that Australia’s clinical trials sector generated $1.6 billion for the Australian economy in 2022. The outcome represents growth of more than 4% on 2019 and has been achieved despite the 2020 pandemic downturn. MTPConnect CEO, Stuart Dignam said, “Clinical trials are a critical step in the R&D pipeline for new treatments and as well as ensuring Australian patients receive the best, safest and most effective treatments, these new figures show clinical trials are more valuable for the economy than ever before.” The report highlights five emerging opportunities for consideration including patient engagement, digital health solutions, precision healthcare, innovative trial designs, and medical device trials. Learn more: https://loom.ly/sfLw7Ks